Annual Revenue:
$75.62M+$75.62M(+100.00%)Summary
- As of today, GLUE annual revenue is $75.62 million, with the most recent change of +$75.62 million (+100.00%) on December 31, 2024.
- During the last 3 years, GLUE annual revenue has risen by +$75.62 million (+100.00%).
- GLUE annual revenue is now at all-time high.
Performance
GLUE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Revenue:
$12.77M-$10.43M(-44.95%)Summary
- As of today, GLUE quarterly revenue is $12.77 million, with the most recent change of -$10.43 million (-44.95%) on September 30, 2025.
- Over the past year, GLUE quarterly revenue has increased by +$3.55 million (+38.54%).
- GLUE quarterly revenue is now -84.97% below its all-time high of $84.93 million, reached on March 31, 2025.
Performance
GLUE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Revenue:
$181.54M+$3.55M(+2.00%)Summary
- As of today, GLUE TTM revenue is $181.54 million, with the most recent change of +$3.55 million (+2.00%) on September 30, 2025.
- Over the past year, GLUE TTM revenue has increased by +$166.56 million (+1112.27%).
- GLUE TTM revenue is now at all-time high.
Performance
GLUE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
GLUE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +100.0% | +38.5% | +1112.3% |
| 3Y3 Years | +100.0% | +100.0% | +100.0% |
| 5Y5 Years | +100.0% | +100.0% | +100.0% |
GLUE Revenue Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | >+9999.0% | -85.0% | >+9999.0% | at high | >+9999.0% |
| 5Y | 5-Year | at high | >+9999.0% | -85.0% | >+9999.0% | at high | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | -85.0% | >+9999.0% | at high | >+9999.0% |
GLUE Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $12.77M(-45.0%) | $181.54M(+2.0%) |
| Jun 2025 | - | $23.19M(-72.7%) | $177.99M(+11.6%) |
| Mar 2025 | - | $84.93M(+40.0%) | $159.49M(+110.9%) |
| Dec 2024 | $75.62M(>+9900.0%) | $60.65M(+558.1%) | $75.62M(+405.0%) |
| Sep 2024 | - | $9.22M(+96.3%) | $14.97M(+160.0%) |
| Jun 2024 | - | $4.70M(+341.3%) | $5.76M(+441.3%) |
| Mar 2024 | - | $1.06M(>+9900.0%) | $1.06M(>+9900.0%) |
| Dec 2023 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2021 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2021 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2020 | $0.00(0.0%) | - | - |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Monte Rosa Therapeutics, Inc. annual revenue?
- What is the all-time high annual revenue for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. annual revenue year-on-year change?
- What is Monte Rosa Therapeutics, Inc. quarterly revenue?
- What is the all-time high quarterly revenue for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. quarterly revenue year-on-year change?
- What is Monte Rosa Therapeutics, Inc. TTM revenue?
- What is the all-time high TTM revenue for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. TTM revenue year-on-year change?
What is Monte Rosa Therapeutics, Inc. annual revenue?
The current annual revenue of GLUE is $75.62M
What is the all-time high annual revenue for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high annual revenue is $75.62M
What is Monte Rosa Therapeutics, Inc. annual revenue year-on-year change?
Over the past year, GLUE annual revenue has changed by +$75.62M (+100.00%)
What is Monte Rosa Therapeutics, Inc. quarterly revenue?
The current quarterly revenue of GLUE is $12.77M
What is the all-time high quarterly revenue for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high quarterly revenue is $84.93M
What is Monte Rosa Therapeutics, Inc. quarterly revenue year-on-year change?
Over the past year, GLUE quarterly revenue has changed by +$3.55M (+38.54%)
What is Monte Rosa Therapeutics, Inc. TTM revenue?
The current TTM revenue of GLUE is $181.54M
What is the all-time high TTM revenue for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high TTM revenue is $181.54M
What is Monte Rosa Therapeutics, Inc. TTM revenue year-on-year change?
Over the past year, GLUE TTM revenue has changed by +$166.56M (+1112.27%)